Risk of hip and renal fracture among dialysis transplant recipients

被引:319
作者
Ball, AM
Gillen, DL
Sherrard, D
Weiss, NS
Emerson, SS
Seliger, SL
Kestenbaum, BR
Stehman-Breen, C
机构
[1] Vet Affairs Pubet Sound Hlth Care Syst, Div Nephrol, Seattle, WA 98108 USA
[2] Univ Washington, Sch Med, Div Nephrol, Seattle, WA USA
[3] Univ Washington, Sch Publ Hlth & Community Med, Dept Biostat, Seattle, WA 98195 USA
[4] Univ Washington, Sch Publ Hlth & Community Med, Dept Epidemiol, Seattle, WA 98195 USA
[5] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2002年 / 288卷 / 23期
关键词
D O I
10.1001/jama.288.23.3014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Renal failure places people at particularly high risk of hip fracture. However, the possible differential impact of dialysis and renal transplantation on this risk is not well understood. Objective To determine if patients who receive kidney transplants are at greater risk of hip fracture compared with those who continue to undergo dialysis. Design, Setting, and Participants Cohort study of 101039 patients with end-stage renal disease placed on the renal transplant waiting list in the United States between January 1, 1990, and December 31, 1999. Main Outcome Measures I Hip fractures, identified from Medicare claims data. Results Among the patients included in this analysis, 971 hip fractures were observed during the follow-up period of 314767 person-years. The incidence rate of hip fracture in patients receiving dialysis was 2.9 per 1000 patients per year compared with 3.3 hip fractures per 1000 patients per year in those who had previously received a renal transplant. Initially, the relative risk (RR) of hip fracture associated with transplantation was 1.34-fold greater when compared with dialysis (adjusted RR, 1.34; 95 % confidence interval [CI], 1.12-1.61) but then decreased by 1 % per month (adjusted RR, 0.99; 95% Cl, 0.98-0.99) until the estimated risk became equal for dialysis and transplant recipients approximately 630 days after transplantation (adjusted RR, 1.00; 95 % Cl, 0.87-1-15). Among transplant recipients, risk of fracture was relatively higher in persons with a prolonged period of dialysis before transplantation. Conclusion The high risk of hi p fracture among dialysis patients is exceeded by that among renal, transplant patients during the first 1 to 3 years after transplantation.
引用
收藏
页码:3014 / 3018
页数:5
相关论文
共 26 条
  • [1] Increased risk of hip fracture among patients with end-stage renal disease
    Alem, AM
    Sherrard, DJ
    Gillen, DL
    Weiss, NS
    Beresford, SA
    Heckbert, SR
    Wong, C
    Stehman-Breen, C
    [J]. KIDNEY INTERNATIONAL, 2000, 58 (01) : 396 - 399
  • [2] LOSS OF REGIONAL BONE-MINERAL DENSITY IN THE 1ST 12 MONTHS FOLLOWING RENAL-TRANSPLANTATION
    ALMOND, MK
    KWAN, JTC
    EVANS, K
    CUNNINGHAM, J
    [J]. NEPHRON, 1994, 66 (01): : 52 - 57
  • [3] Factors affecting bone mineral density in renal transplant patients
    Caglar, M
    Adeera, L
    [J]. ANNALS OF NUCLEAR MEDICINE, 1999, 13 (03) : 141 - 145
  • [4] Mechanisms of glucocorticoid action in bone: Implications to glucocorticoid-induced osteoporosis
    Canalis, E
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (10) : 3441 - 3447
  • [5] Bone disease in patients with long-term renal transplantation and normal renal function
    Carlini, RG
    Rojas, E
    Weisinger, JR
    Lopez, M
    Martinis, R
    Arminio, A
    Bellorin-Font, E
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (01) : 160 - 166
  • [6] Evidence for a role for insulin-like growth factor binding proteins in glucocorticoid inhibition of normal human osteoblast-like cell proliferation
    Chevalley, T
    Strong, DD
    Mohan, S
    Baylink, DJ
    Linkhart, TA
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1996, 134 (05) : 591 - 601
  • [7] Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone
    Coco, M
    Rush, H
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (06) : 1115 - 1121
  • [8] CUNDY T, 1983, Q J MED, V52, P67
  • [9] Dalen N, 1973, Clin Nephrol, V1, P338
  • [10] Epstein Sol, 1995, Current Opinion in Rheumatology, V7, P255, DOI 10.1097/00002281-199505000-00018